logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Tetracycline-class Drug class drugs

    FiltersReset Filters
    5 results

    • doxycycline hyclate

      (doxycycline hyclate)
      Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
      Usage: Doxycycline hyclate delayed-release tablets are indicated for various infections, including rickettsial infections, sexually transmitted infections, respiratory tract infections, specific bacterial infections, and ophthalmic infections. Additionally, they are used for anthrax treatment, alternative therapy when penicillin is contraindicated, severe acne adjunct therapy, acute intestinal amebiasis, and malaria prophylaxis.

    • oracea

      (DOXYCYCLINE)
      Galderma Laboratories, L.P.
      Usage: ORACEA is indicated for treating inflammatory lesions of rosacea (papules and pustules) in adults but is not effective for generalized redness. It is not approved for treating infections or bacterial prophylaxis and has not been evaluated for other rosacea symptoms like erythema or ocular components.

    • seysara

      (sarecycline hydrochloride)
      Almirall, LLC
      Usage: SEYSARA (sarecycline) is indicated for treating inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients aged 9 and older. Efficacy beyond 12 weeks and safety beyond 12 months are not established, and it is not evaluated for infections. Use as indicated to prevent drug resistance.

    • targadox

      (doxycycline hyclate)
      Journey Medical Corporation
      Usage: TARGADOX® (doxycycline) is indicated for treating infections caused by susceptible bacteria, including certain rickettsial diseases, respiratory infections, and Chlamydia infections. It is also used for prophylaxis against malaria in short-term travelers. The drug should be used to prevent antibiotic resistance.

    • zilxi

      (Minocycline)
      Journey Medical Corporation
      Usage: ZILXI is indicated for treating inflammatory lesions of rosacea in adults. It has not been evaluated for infection treatment and should be used as directed to prevent drug-resistant bacteria and maintain the effectiveness of other antibacterial drugs.